Dermapharm Holding SE
XETRA:DMP
Dermapharm Holding SE
XETRA:DMP
Price:
41.85
EUR
-2.9%
Market Closed
Market Cap:
€2.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Dermapharm Holding SE
XETRA:DMP
|
DE |
|
Rockchip Electronics Co Ltd
SSE:603893
|
CN |
|
IQ-AI Ltd
LSE:IQAI
|
JE |
|
A
|
Avid Technology Inc
F:AVD
|
US |
|
A
|
Atlanta Poland SA
WSE:ATP
|
PL |
|
Zeta Global Holdings Corp
NYSE:ZETA
|
US |
|
Bank Ganesha Tbk PT
IDX:BGTG
|
ID |
|
A
|
Australian Bond Exchange Holdings Ltd
ASX:ABE
|
AU |
|
LiqTech International Inc
NASDAQ:LIQT
|
DK |
Multiples-Based Value
The Multiples-Based Value of one
DMP
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 41.85 EUR,
Dermapharm Holding SE
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DMP Multiples-Based Value
LOCKED
Multiples Across Competitors
DMP Competitors Multiples
Dermapharm Holding SE Competitors
Dermapharm Holding SE Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
Dermapharm Holding SE
XETRA:DMP
|
2.3B EUR | 1.9 | 17 | 8.8 | 12.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
900.7B USD | 13.8 | 43.6 | 29.4 | 31.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.2 | 11.4 | 12.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
304.8B USD | 4.7 | 16.7 | 10.3 | 12.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.2 | 20.8 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.2B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.2B USD | 2.5 | 16.9 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
